Nathan Slaughter, Chief Investment Strategist of The Daily Paycheck and High-Yield Investing, has developed a long and successful track record over the years by finding profitable investments no matter where they hide. Nathan's previous experience includes a long tenure at AXA/Equitable Advisors, one of the world's largest financial planning firms. He also honed his research skills at Morgan Keegan, where he managed millions in portfolio assets and performed consultative retirement planning services. To reach more investors, Nathan switched gears in 2004 and began writing full-time. He has since published hundreds of articles for a variety of prominent online and print publications. Nathan has interviewed industry insiders like Paul Weisbruch and CEOs like Tom Evans of Bankrate.com, and has been quoted in the Los Angeles Times for his expertise on economic moats. Nathan's educational background includes NASD Series 6, 7, 63, & 65 certifications, as well as a degree in Finance/Investment Management from Sam M. Walton School of Business, where he received a full academic scholarship. When not following the market, Nathan enjoys watching his favorite baseball team, the Cubs, and camping and fishing with his family.
Analyst Articles
Benjamin Franklin once referred to the magic of compound interest as the “8th wonder of the universe” for its ability to systematically accumulate wealth. Inflation, then, which systematically destroys wealth, must be an evil twin. Nothing is quite like the relentless… Read More
I hadn’t spoken to my friend Harriet for almost a year. We were really close in university, but with her living several hundred miles from me, we drifted apart. So a few weeks ago, I picked up the phone, dialed, and awaited with pleasure her cheery “Hello.”… Read More
With the weak economy, drug makers have been scaling back their drug development plans. The slowdown has trickled down to the so-called contract research organizations (CRO), which help pharmaceutical and biotechnology firms manage the necessary clinical trials for a drug to be licensed… Read More
An unprecedented level of industrial expansion during the past two decades has not only made China wealthy. It’s made the country really dirty. Now comes the clean up. Years of industrial growth, largely powered by coal, have left China choking in smog. Cities smolder… Read More
Bill Gates evidently made a New Year’s resolution last year — one that he didn’t say much about. Of course, when you’re Bill Gates you don’t have to say much to make the things you resolve happen. In fact, Gates may have only said… Read More
There are a plethora of Chinese ETFs already on the market, so what can investors expect from another offering? Emerging powerhouses of Chinese business. This ETF isn’t limited by size and has free reign to invest across… Read More
Oil at $200 per barrel: That’s what an analyst at Goldman Sachs (NYSE: GS) predicted in May 2008. At the time, oil had just hit a record high , surpassing $110 per barrel. A month later, the CEO of the Russian energy company Gazprom predicted $250 per barrel oil. Read More
Back in July, investors eagerly anticipated Alcoa’s (NYSE: AA) second quarter financial snapshot — not for any particular interest in the aluminum sector, but simply because the Dow component happens to kickoff earnings season each quarter. Fortunately, the company pleased the… Read More
“Give me a lever long enough,” said Archimedes, “and a place to stand, and I will move the world.” If the old Greek were alive today, he might well work for Fluor (NYSE: FLR, $41.95), one of the world’s largest public engineering and construction companies. Fluor designs… Read More
I’m always on the lookout for the right combination of fundamental and technical factors to get a trader’s edge. Look carefully at the following two charts — the first covering the last three months of 2008 and the first three of 2009, and the second covering the… Read More
